MedPath

Comparison of Allows Measurement of Cardiac Output Between Clearsight System and Transpulmonary Thermodilution

Conditions
Shock
Cardiac Output, Low
Registration Number
NCT02728791
Lead Sponsor
University Hospital, Brest
Brief Summary

Correlation study between the data provided by two measurement systems, trans- pulmonary thermodilution and ClearSight © (non invasive), to determine the interest in routine use (cardiac output, cardiac index, stroke volume and blood pressure).

Detailed Description

Since 2014, Edwards society has developed a completely non-invasive monitoring device for measurement of blood pressure and continuous cardiac output without inserting foreign intravascular bodies in the patient. Initially tested on healthy volunteers cardiac disease -free, the correlation with the other devices seems to be good. If this ClearSight © system show a relevant accuracy in measuring blood pressure and cardiac output with a specific ICU hospitalized population, it could justify its place in the therapeutic arsenal of monitoring in intensive care.

This is a common care ,prospective observational single center study , concerning the results of blood pressure , cardiac output values and their variations.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
40
Inclusion Criteria
  • age>18
  • hospitalized in surgical ICU, with hemodynamic instability or vaso-active drugs
  • No opposition formulated
Exclusion Criteria
  • Impossibility of establishment of one of the cardiac output measurement devices
  • Pregnant woman
  • Refuse to participate

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Comparison of values and changes in cardiac index between the two devices2 days
Secondary Outcome Measures
NameTimeMethod
Comparison of values and variations in mean arterial pressure between the two devices2 days
Comparison of values and variations in mean stroke volume variation between the two devices2 days
Comparison of values and variations in mean cardiac output between the two devices2 days

Trial Locations

Locations (1)

CHRU BREST, Hôpital de la Cavale Blanche

🇫🇷

Brest, France

CHRU BREST, Hôpital de la Cavale Blanche
🇫🇷Brest, France
jean-ferréol JF OILLEAU
Contact
0298347961
jean-ferreol.oilleau@chu-brest.fr
© Copyright 2025. All Rights Reserved by MedPath